Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 264 participants.

Also called NCT03511313

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 264 participants (planned count) (from the registry)
Sponsor
Synaptic Medical Corporation (from the registry)
Registry
  • NCT NCT03511313
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03511313. Randomized; single masking; primary purpose treatment. Start 2018-04-11 (actual); primary completion 2020-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension
Condition
Primary Hypertension
Intervention (Device)
Renal denervation
Intervention (Diagnostic test)
Renal angiography
Lead sponsor
Synaptic Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct03511313
Content hash
1c1d63b9bb58e3d7c47bbf216ef070587a28531691ff07f85bc2218e5c17bc47